Reflections: What Really Matters  |  Teacher Insights: New Harvard Online course course prepares professionals for a data-driven world  |  Parent Interventions: Research shows lullabies in any language relax babies  |  International Edu News: 'Plastic bags could be 'eco-friendlier' than paper and cotton bags'  |  Leadership Instincts: Start-up with plastic waste recycling solution wins top prize at ideasinc 2020  |  International Edu News: Frailty, old age and comorbidity main predictors of death from Covid-19  |  Leadership Instincts: Cyber centre to reduce digital harm  |  Policy Indications: New funding to improve water security for 10 million people in Africa and Asia  |  International Edu News: UCL hosts global conference on UN Sustainable Development Goals  |  International Edu News: Medium-term impact of COVID-19 revealed in new study  |  International Edu News: Extremely rapid diagnostic test for Covid-19  |  Teacher Insights: Cambridge University Press to join with Cambridge Assessment  |  National Edu News: Minister inaugurates new Diamond Jubilee Lecture Hall Complex of NIT Jamshedpur  |  Education Information: CSIR partnered clinical trials website “CUReD” on Repurposed Drugs for Covid- 19  |  Teacher Insights: The 6th India International Science Festival to be held in Virtual format  |  
September 24, 2020 Thursday 12:15:20 PM IST

CSIR and Mylan announce partnership

Science Innovations

The Council of Scientific & Industrial Research (CSIR), India’s premier research organization, and Mylan Laboratories Limited, the India-based subsidiary of leading global pharmaceutical company Mylan, today announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic. Under the partnership, CSIR’s constituent laboratory Indian Institute of Chemical Technology (CSIR-IICT), and Mylan will collaborate to identify potential therapies for COVID-19.

A series of clinical trials will be conducted towards new and innovative solutions to manage COVID-19 pandemic in India as part of this collaboration. The first of the clinical trial to be rolled out is a multiple arm phase 3 study that will be conducted in adult patients with mild to moderate COVID -19 at risk of complications.

The application for the clinical trials has been submitted to the Drugs Controller General of India (DCGI) for regulatory approval.

CSIR has appointed Dr. Ram Vishwakarma, Honorary Advisor to DG-CSIR and former Director CSIR-IIIM (Indian Institute of Integrative Medicine) as a mentor to lead this collaboration.


The Council of Scientific & Industrial Research (CSIR), known for its cutting-edge R&D knowledgebase in diverse Science & Technology areas, is a contemporary and premier R&D organization. Having a pan-India presence, CSIR has a dynamic network of 38 national laboratories, 39 outreach centres, 3 Innovation Complexes and 5 units. CSIR covers a wide spectrum of science and technology – from oceanography, geophysics, chemicals, drugs, genomics, biotechnology and nanotechnology to mining, aeronautics, instrumentation, environmental engineering and information technology.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. It is one of the world's largest producers of active pharmaceutical ingredients.



Comments